Catalent Pharma Solutions, Thomson Avenue

The property comprises a substantial two storey former biomanufacturing facility arranged over ground, mezzanine and first floors. The property also benefits from access via the rear through the service yard, a car park for approximately 88 cars and an internal eaves height of 12m (39 ft) to the production area. The property is also fully fitted out with the benefit of a full roster of specialist equipment. Originally developed as the Vaccine Manufacturing Innovation Centre (VMIC) reportedly costing £205m to deliver, this 171,619 sq. ft. GIA facility has since been repurposed by the current owner while retaining its original design to mass produce vaccine treatments. - Auction 6th May 2026